Stratton R D, Wagner R H, Webster W P, Brinkhous K M
Proc Natl Acad Sci U S A. 1975 Oct;72(10):4167-71. doi: 10.1073/pnas.72.10.4167.
A circulating plasma inhibitor of the "von Willebrand factor" was observed in a multiply tranfused subject with severe von Willebrand's disease. The platelet-active von Willebrand factor is associated with a plasma protein macromolecular complex that is deficient in the disease. The inhibitor appears to be an IgG antibody, kappa type, based on neutralization tests with goat antisera to specific human immunoglobulins. The IgG and inhibitor separated out together in plasma fractions obtained by "salting-out" and chromatographic procedures. Two separate inhibitor neutralization tests for the platelet-active factor, one with human plasma and ristocetin, the other with bovine plasma, gave similar results, based on the macroscopic aggregation time test of fixed human platelets. With cryoprecipitate transfusions the inhibitor was transiently neutralized with the temporary appearance of von Willebrand factor, factor VIII, and factor VIII-like antigen in the plasma. The plasma inhibitor level increased after transfusion, suggesting an anamnestic response. Lower titer inhibitor plasmas neutralized only the platelet activity. Highest titer plasma also neutralized human factor VIII, but only in part; it did not neutralize either bovine factor VIII or the human small active factor VIII fragment. The anti-factor VIII activity of the von Willebrand factor inhibitor may be due to steric hindrance, dependent on the spatial relationship of factor VIII sites on the macromolecular complex.
在一名患有严重血管性血友病且多次输血的患者体内,观察到一种循环血浆中的“血管性血友病因子”抑制剂。具有血小板活性的血管性血友病因子与一种血浆蛋白大分子复合物相关,而该复合物在这种疾病中是缺乏的。基于用针对特定人类免疫球蛋白的山羊抗血清进行的中和试验,该抑制剂似乎是一种κ型IgG抗体。IgG和抑制剂在通过“盐析”和色谱法获得的血浆组分中一起分离出来。基于固定人类血小板的宏观聚集时间试验,对具有血小板活性的因子进行的两项单独的抑制剂中和试验,一项用人血浆和瑞斯托霉素,另一项用牛血浆,结果相似。通过冷沉淀输血,抑制剂被短暂中和,同时血浆中出现血管性血友病因子、因子VIII和因子VIII样抗原。输血后血浆抑制剂水平升高,提示存在回忆反应。低滴度抑制剂血浆仅中和血小板活性。高滴度血浆也能中和人类因子VIII,但只是部分中和;它既不能中和牛因子VIII,也不能中和人类小活性因子VIII片段。血管性血友病因子抑制剂的抗因子VIII活性可能是由于空间位阻,这取决于大分子复合物上因子VIII位点的空间关系。